Notably, CAFs are marked by the higher expression of SPARC, COL4A1, TAGLN, CALD1, FBLN1, RARRES2, CCDC80, SFRP2, and VCAN in BA patients. This evidence concerns the gene CCDC80 and breast angiosarcoma.